🇺🇸 FDA
Patent

US 7691579

Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen

granted A61KA61K2039/5258A61K2039/55516

Quick answer

US patent 7691579 (Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5258, A61K2039/55516, A61K2039/55522, A61K39/39